CD274 and neoplasm: Isolated patient cases, albeit limited, have reported success with ICB therapy in patients with elevated tumor PD-L1 expression, suggesting potential for ICB therapy, particularly in MPNST patients with inoperable or metastatic disease [23,24,104].